|Articles|March 13, 2018
Certara Launches Quantitative Systems Pharmacology Consortium on Immuno-oncology
Advertisement
Certara announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium. This new QSP brings together biopharmaceutical companies to create a simulator that can model clinical populations of cancer patients in order to improve the development of immuno-oncology therapies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
